
Gender distribution of oncology clinical trials globally 2008-2013, by cancer
This statistic depicts the gender distribution of clinical trials for select oncology drugs that were approved worldwide between 2008 and 2013, by cancer. According to the data, 57 percent of those enrolled in clinical trials for colorectal cancer drugs were male.